Dual-Energy Computed Tomography for Brain Metastasis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Brain Metastasis+1 MoreDual-Energy Computed Tomography - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial uses DECT to image patients with solid organ cancer that has spread to the brain. DECT may help find and diagnose tumor cells and find out how far the tumor cells have spread in the brain.

Eligible Conditions
  • Cancer
  • Brain Metastasis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Up to 2 years

Up to 2 years
Accuracy of CT
Best diagnostic performance of computed tomography (CT) reconstruction parameters

Trial Safety

Trial Design

1 Treatment Group

Diagnostic (DECT)
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Dual-Energy Computed Tomography · No Placebo Group · N/A

Diagnostic (DECT)
Procedure
Experimental Group · 1 Intervention: Dual-Energy Computed Tomography · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 2 years

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,085 Previous Clinical Trials
41,141,461 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,805 Previous Clinical Trials
1,790,329 Total Patients Enrolled
Jason M JohnsonPrincipal InvestigatorM.D. Anderson Cancer Center
6 Previous Clinical Trials
178 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
MRI of the brain with contrast, positive for two or more metastatic lesions.
You are planned to have stereotactic radiosurgery.
One lesion with a single greatest diameter on contrast-enhanced MRI of 1 cm or greater.